Treatment of refractory convulsive status epilepticus in children: other therapies

Area of Science:

• Neurology
• Critical Care Medicine
• Pharmacology

Background:

• Refractory convulsive status epilepticus (RCSE) is defined by persistent seizures despite benzodiazepine and anticonvulsant treatment.
• Current management often involves drug-induced anesthesia, necessitating intensive care and posing significant complication risks.
• When standard treatments fail, alternative therapeutic strategies are crucial for seizure control.

Purpose of the Study:

• To review the existing literature on advanced treatment options for refractory convulsive status epilepticus.
• To evaluate the efficacy and potential side effects of non-anesthetic interventions for RCSE.
• To provide an evidence-based overview of alternative therapies for persistent seizures.

Main Methods:

• Literature review of studies investigating treatments for RCSE beyond initial drug therapy.
• Analysis of evidence supporting the use of ketogenic diet, hypothermia, inhalational anesthetic agents, and immune-modulating therapies.
• Assessment of reported outcomes and adverse events associated with these alternative treatments.

Main Results:

• Evidence for the efficacy of ketogenic diet in RCSE varies, with some studies showing promise.
• Hypothermia has demonstrated potential in select RCSE cases, but requires careful monitoring.
• Inhalational anesthetic agents offer an alternative for refractory cases, though data is limited.
• Immune-modulating therapies are considered for RCSE with suspected autoimmune etiology.

Conclusions:

• Several alternative treatment modalities exist for refractory convulsive status epilepticus when first- and second-line therapies fail.
• Further research is needed to establish definitive guidelines for the use of ketogenic diet, hypothermia, and other advanced therapies in RCSE.
• Individualized treatment approaches are essential, considering patient-specific factors and evidence for each modality.